Clinical Trial: A Study of LY4065967 in Healthy Participants

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607483) titled 'A Study of LY4065967 in Healthy Participants' on May 19.

Brief Summary: The main purpose of this study is to compare 3 different forms of LY4065967 - a tablet and 2 types of capsule - to see how much and how quickly each gets into the bloodstream after it is swallowed, and to check for any side effects. For each participant, the study will last about 7 weeks and will include 3 stays in the Clinical Research Unit (CRU). Each stay will last 3 nights.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY4065967 Tablet

Administered orally

DRUG: LY4065967 Formulated Capsule

Administered...